FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA - Spain 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
2019
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Networking Rank (Reputation):500-600
2016
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Networking Rank (Reputation):600-700
2015
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:700-800
Total Number of Projects:800-900
Networking Rank (Reputation):800-900
Partner Constancy:700-800
Project Leadership Index:700-800
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2014-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 48
As coordinator: 4
As participant: 42
Sole participant: 2
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 9.637.083 414.433 2
2022 172.932 50.641.703 1.904.662 1 6
2021 0 30.994.597 1.926.486 5
2020 18.258.323 39.692.731 4.951.195 3 7
2019 12.004.953 37.920.546 3.699.157 1 5
2018 0 8.979.119 626.348 2
2017 0 36.744.950 2.990.666 5
2016 0 29.991.564 1.717.060 5
2015 0 40.497.896 816.006 4
2014 173.371 3.687.558 400.052 1 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS9
KATHOLIEKE UNIVERSITEIT LEUVEN9
UNIVERSITAIR MEDISCH CENTRUM UTRECHT9
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
UNIVERSITY COLLEGE LONDON8
KAROLINSKA INSTITUTE7
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
KING'S COLLEGE LONDON6
SERVICIO MADRILENO DE SALUD6
UNIVERSITAETSKLINIKUM HEIDELBERG6
UNIVERSITY OF BOLOGNA6
ACADEMISCH ZIEKENHUIS GRONINGEN5
EATRIS ERIC5
HOSPICES CIVILS DE LYON5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
STICHTING KATHOLIEKE UNIVERSITEIT5
UNIVERSITY OF AARHUS5
UNIVERSITY OF BERGEN5
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE4
COMMISSARIAT A L'ENERGIE ATOMIQUE4
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
INSTITUT PASTEUR4
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT4
OSPEDALE SAN RAFFAELE4
TARTU ULIKOOL4
UNIVERSITA DEGLI STUDI DI PADOVA4
UNIVERSITAT DE BARCELONA4
ACADEMIC MEDICAL CENTRE AMSTERDAM3
ANAXOMICS BIOTECH S L3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS3
CONCENTRIS RESEARCH MANAGEMENT3
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
FAKULTNI NEMOCNICE U SV ANNY V BRNE3
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA3
INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL3
JANSSEN PHARMACEUTICA NV3
MEDIZINISCHE HOCHSCHULE HANNOVER3
NOVARTIS PHARMA3
REGION HOVEDSTADEN3
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM3
STICHTING RADBOUD UNIVERSITEIT3
STICHTING VUMC3
STROKE ALLIANCE FOR EUROPE3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA3
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN3
THE QUEEN'S UNIVERSITY OF BELFAST3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF3
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK3
UNIVERSITY OF BIRMINGHAM3
VIB VZW3
WAGENINGEN UNIVERSITY3
ABO AKADEMI2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ADD INFORMATION SERVICES2
AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM2
ALZHEIMER EUROPE2
ASPHALION SL2
AUSTRALO INTERINNOV MARKETING LAB SL2
BARCELONA SUPERCOMPUTING CENTERCENTRO NACIONAL DE SUPERCOMPUTACION2
BIOKERALTY RESEARCH INSTITUTE AIE2
CENTRE DE REGULACIO GENOMICA2
CENTRE HOSPITALIER SAINTE ANNE DE PARIS2
CHU HOPITAUX DE BORDEAUX2
CONSIGLIO NAZIONALE DELLE RICERCHE2
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP2
DATAWIZARD2
EINDHOVEN UNIVERSITY OF TECHNOLOGY2
ETABLISSEMENT FRANCAIS DU SANG2
EUROPEAN AIDS TREATMENT GROUP EV2
EUROPEAN LIVER PATIENTS ASSOCIATION2
EUROSCAN INTERNATIONAL NETWORK EV2
FORUM DES PATIENTS EUROPEENS2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ2
GOETEBORGS UNIVERSITET2
HUMANITAS MIRASOLE2
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON2
INSERM TRANSFERT2
INSTITUT CATALA DE LA SALUT2
INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
IRCCS AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA2
ISOFT SANIDAD2
ISTITUTO SUPERIORE DI SANITA2
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN2
KARLSRUHER INSTITUT FUER TECHNOLOGIE2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LEIDEN UNIVERSITY2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
LINKOPINGS UNIVERSITET2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MASARYKOVA UNIVERZITA2

Constancy:

Total number of partners: 864
Partner loyalty:
Frequent Partner: (> 2 projects): 239
Rare Partner: 625
Frequent / Rare Partner Ratio: 0.38

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Embodied Social Experiences in Hybrid Shared Spaces SHARESPACEparticipant5.947.57416
2023-01-01A Multiplexed Plasmo-Photonic Biosensing Platform For Rapid And Intelligent Sepsis Diagnosis At The Point-Of-Care AMBROSIAparticipant3.689.51013
2022-12-01Synthetic generation of hematological data over federated computing frameworks SYNTHEMAparticipant6.514.56016
2022-10-01A European Health Data Toolbox for Enhancing Cardiology Data Interoperability, Reusability and Privacy DataTools4Heartparticipant7.747.90516
2022-09-01IMPACT OF SENSORY AND STRESSFUL STIMULI IN A PRECLINICAL MODEL OF CHRONIC MIGRAINE SENSOMIGcoordinator172.9321
2022-06-01The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine UNDINEparticipant6.718.13921
2022-05-01V A L I D A T E - Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment VALIDATEparticipant5.918.17510
2022-04-01Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging. QUSTomparticipant2.744.3006
2022-02-01Integrated Services for Infectious Disease Outbreak Research ISIDOReparticipant20.998.624154
2021-12-01RBD Dimer recombinant protein vaccine against SARSCoV2 RBDCOVparticipant9.779.21116
2021-06-01A KEY TO THE RATIONAL DESIGN OF EXTRACELLULAR VESICLES-MIMICKING NANOPARTICLES MIMIC-KeYparticipant2.902.5287
2021-04-01Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients TIMESPANparticipant5.999.98617
2021-03-01European Rare dIsease research Coordination and support Action ERICAparticipant2.313.80927
2021-01-01Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases GenoMed4ALLparticipant9.999.06428
2020-10-01Spinal Muscular Atrophy (SMA) beyond motoneuron degeneration: multi-system aspects SMABEYONDparticipant2.142.7359
2020-09-01Self Conversation in Virtual Reality Embodiment to Enhance Healthier Lifestyles Among Obese People SOCRATESparticipant1.748.2084
2020-01-01Immune profiling to guide host-directed interventions to cure HBV infections IP-cure-Bparticipant9.983.02916
2020-01-01Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe DISCOvERIEcoordinator6.000.00021
2020-01-01DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY AFFECT-EUparticipant5.947.92526
2020-01-01Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome EXIMIOUSparticipant10.878.33115
2020-01-01Erythrocytes properties and viability in dependence of flow and extra-cellular environment EVIDENCEparticipant3.993.48013
2020-01-01DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES DocTIScoordinator6.260.05010
2020-01-01Consolidating the capacities of EATRIS-ERIC for Personalised Medicine EATRIS-Plusparticipant4.999.02324
2020-01-01Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia RECOGNISEDcoordinator5.998.27325
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLcoordinator12.004.95337
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-04-01European-Latin American TB Research Collaboration Network EUSAT-RCSparticipant910.8009
2019-04-01AuTonomous intraLuminAl Surgery ATLASparticipant3.944.50921
2019-04-01SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH. SAFE-N-MEDTECHparticipant14.534.36628
2019-01-01Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections FunHoMicparticipant3.530.87115
2018-10-01Evolvable platform for programmable nanoparticle-based cancer therapies EVO-NANOparticipant2.988.6597
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2017-12-01PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation PRESTIGE-AFparticipant6.958.89612
2017-10-01Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration nTRACKparticipant6.863.86512
2017-09-01Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviours Eat2beNICEparticipant11.144.56218
2017-01-01Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial PROOFparticipant5.778.82712
2017-01-01SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPEparticipant5.998.80018
2016-10-01Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 MOPEADparticipant2.043.00015
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025
2016-04-01Nanomedicine upscaling for early clinical phases of multimodal cancer therapy NoCanTherparticipant7.113.77912
2016-01-01Brain injury and trauma monitoring using advanced photonics BitMapparticipant3.835.76411
2016-01-01Comorbid Conditions of Attention deficit / hyperactivity disorder CoCAparticipant5.999.02117
2015-09-01REgenerative Stem cell therapy for STroke in Europe RESSTOREparticipant6.338.25931
2015-08-01iABC Programme IABC PROGRAMMEparticipant24.331.60922
2015-05-01Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. CARBALIVEparticipant5.913.08014
2015-01-01Mastering skills in the training Network for attention deficit hyperactivity and autism spectrum Disorders MiNDparticipant3.914.94812
2014-04-01Unraveling metabolic settings and targeting metabolic enzymes with selective lethality in BRAF and NRAS mutant melanoma tumors METABOSETcoordinator173.3711
2014-02-01European Training in Neural Regulation of Intestinal Function NEUROGUTparticipant3.687.55812